DR

Dr. M Madan Mohan Reddy

Senior Vice President at Novugen

Dr. M Madan Mohan Reddy currently serves as Senior Vice President at Novugen since December 2022. Prior to this role, Dr. Mohan Reddy was employed at Eisai Pharmaceuticals India from December 2008 to January 2023, where responsibilities included leading Regional Quality and Regulatory Affairs. Earlier experience includes serving as Manager and Head of Site Quality Assurance at Dr. Reddy's from September 2003 to November 2008. Dr. Mohan Reddy holds a Doctor of Philosophy in Pharmaceutical Sciences from Andhra University, a Master of Science in Quality Management from Birla Institute of Technology and Science, Pilani, and a Bachelor of Pharmacy from Gulbarga University.

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Novugen

Novugen is a wholly owned subsidiary company of a UAE based group, SciTech International. We are a vertically integrated pharmaceutical company, from Active Pharmaceutical Ingredients (API) to Finished Products Research & Development (R&D) and manufacturing for all therapeutic areas including oncology. With over 30 years of experience in the global healthcare landscape, Novugen bring hard-to-source and technology-intensive products to the market with the aim to provide early access to affordable, life-changing drugs of the highest quality for patients worldwide. Malaysia is home to Novugen’s FIRST USFDA Approved pharmaceutical manufacturing facilities in the country and the Only in Southeast Asia, focusing on oral solid dosage forms for general medicines as well as manufacturing of highly potent Oncology drugs. Our manufacturing facility is also Halal compliant, a reflection of our commitment to respond to the increasing demand of Halal products locally and globally. While we appreciate your interest and interaction in Novugen's page, we ask that you post, comment, or share any content respectfully. We reserve the right to remove spam and activities that directly or indirectly suggest slanderous, libelous, obscene, offensive, and indecent remarks. The content of this page is also for informational purposes only and not intended to substitute professional medical advice.


Employees

501-1,000

Links